Fundraising FoxCambiotics
1 known investors
Find your way into Cambiotics
Sign up to find every way you can get introduced to Cambiotics
- Your email: who you already know at Cambiotics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cambiotics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Cambiotics develops a precision-formulated probiotic whose bacterial strains interact with PFAS ("forever chemicals") in the gut to support their removal from the body through the digestive system. Based on University of Cambridge research, it targets consumers exposed to PFAS, including first responders such as firefighters and military personnel, with a US product launch planned for 2026.
Founders & leadership
AL
Anna LindellVP of Technology & Co-founder
KR
Kiran Raosaheb PatilCo-founder
PH
Peter Holme JensenCo-founder
Investors · 1
Frequently asked questions
- What does Cambiotics do?
- Cambiotics develops a precision-formulated probiotic whose bacterial strains interact with PFAS ("forever chemicals") in the gut to support their removal from the body through the digestive system. Based on University of Cambridge research, it targets consumers exposed to PFAS, including first responders such as firefighters and military personnel, with a US product launch planned for 2026.
- Who are Cambiotics's investors?
- Cambiotics's investors include Collaborative Fund.